Home › Funds › Trails Edge Capital Partners, LP › IMCR

Trails Edge Capital Partners, LP position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Trails Edge Capital Partners, LP reported holding 1,063,234 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$33.8M, representing 5.36% of its reported portfolio and ranking #3 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IMCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.06M sh
Reported value held$33.76M
Portfolio Weight5.36%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's IMCR position evolved

Trails Edge Capital Partners, LP first disclosed a stake in IMCR in Q4 2025 at 682,597 shares (US$23.7M). The position peaked in Q2 2026 at 1,063,234 shares, worth US$33.8M. Across 3 filings, Trails Edge Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,063,234 shares valued at US$33.8M — an increase of 380,637 shares quarter over quarter.. Notable position changes include a 56% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 682.60K $23.69M New
Q1 2026 682.60K $20.58M Hold
Q2 2026 1.06M $33.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held IMCR?

Trails Edge Capital Partners, LP has disclosed IMCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Trails Edge Capital Partners, LP's current position in IMCR?

As of Q2 2026, Trails Edge Capital Partners, LP holds 1.06M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $33.76M, representing 5.36% of its reported portfolio and ranking #3.

Has Trails Edge Capital Partners, LP been buying or selling IMCR?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP increased its position in IMCR. The position peaked in Q2 2026 at 1.06M shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.